Recent blood pressure trends reflect progress in hypertension control, but prevalent drug therapy precludes direct estimation of the component due to primary prevention. In data gathered on persons aged 35-74 years in three successive US health examination surveys , systolic blood pressure levels assuming no drug therapy were imputed by reassigning blood pressure to the upper end of the distribution for respondents reporting use of antihypertensive medication. Blood pressure was partitioned into four ordinal categories based on weighted percentiles of the 1960-1962 distributions for 35-to 44-year-old males and females who reported no use of antihypertensive medication. Cumulative loglt models (a = 0.01) were used to estimate ageand sex-specific trends for blacks and whites within two strata (<25 or ^25) of body mass index (BMI) (weight (kg)/height (m) 2 ). Before imputation, systolic blood pressure decreased between 1960 and 1980; after imputation, significant decreases remained only in 35-to 44-year-olds. Strong associations of black race and BMI a25 with higher blood pressures were present in models with and without drug therapy. Thus, according to the models, there has been little progress in decreasing racial or BMI-related blood pressure differentials. Above the age of 44 years, blood pressure trends were largely attributable to medication use. In contrast, data for 35-to 44-year-olds suggest progress in primary prevention. Am J Epidemiol 1998; 148:528-38. antihypertensive agents; blacks; blood pressure; body weight; ethnic groups; hypertension; obesity Due in large part to the success of efforts to identify persons with high blood pressure and refer them to physicians for appropriate treatment, the majority of persons with hypertension are aware of this condition, and at least half of such individuals are being treated with antihypertensive medication (1). This widespread treatment for hypertension may be enhancing a secular decline in blood pressure due to primary prevention of blood pressure elevation. However, it is also possible that any decrease in blood pressure levels resulting
from antihypertensive therapy is obscuring a lack of progress in the primary prevention of hypertension. Decreases due to drug therapy could be occurring while underlying blood pressure trends are stable or even rising.
In a previous analysis of secular trends in the blood pressures of 18-to 34-year-olds (2), we observed a decline in systolic blood pressure among males and among females with a body mass index (BMI) (weight (kg)/height (m) 2 ) less than 25. This finding indicated success in primary prevention, because the small number of persons (<1.5 percent) reporting antihypertensive medication use were excluded from the analysis sample. The prevalence of antihypertensive drug treatment at ages 35 and over is higher, however, and excluding persons on medication risks introducing a substantial bias towards lower blood pressures as the prevalence of drug therapy increases. That is, individuals taking antihypertensive medications presumably had higher blood pressure levels initially than those not taking such drugs. Furthermore, the bias would be greatest for those most likely to be treated for hypertension-i.e., persons in high risk groups such as blacks or the overweight.
As an alternative approach to evaluating blood pressure trends without considering drug therapy, we used an imputation method that involved reassigning the blood pressure of anyone reporting the use of antihypertensive medication to the upper end of the distribution. We applied this approach to statistical models of blood pressure trends for 35-to 74-year-old males and females in three successive US national health examination surveys conducted between 1960 and 1980. Substantial increases in hypertension awareness and in the prescription of antihypertensive medications occurred in the United States during this period (3) . We estimated the effects of drug treatment indirectly by examining the statistical significance of time trends before and after the imputation.
MATERIALS AND METHODS Population and sample
Data used for these analyses were obtained from the National Health Examination Survey, cycle I (NHES I), conducted from 1960 to 1962, and the first and second National Health and Nutrition Examination Surveys (NHANES I and NHANES II), conducted, respectively, from 1971 to 1975 and 1976 to 1980. Different cross-sectional probability samples were drawn from each survey using multistage, complex sample designs that included provision for oversampling to improve the reliability of estimates for certain population subgroups (4) (5) (6) . Nationally representative estimates for the US civilian, noninstitutionalized population can be obtained from these data by incorporating sample weights reflecting different probabilities of selection and differential nonresponse patterns for various subgroups.
These analyses included all respondents with race coded as black or white who were between the ages of 35 and 74 years at the time of interview, with the exception of persons with missing data on blood pressure, medication status, weight, or height and females who were pregnant at the time of examination. The numbers excluded were minimal: for males, 29 respondents from the NHES I sample, 19 from the NHANES I sample, and 25 from the NHANES H sample (0.78 percent of a total sample of 9,328); for females, 78 respondents from the NHES I sample, 52 from the NHANES I sample, and 112 from the NHANES H sample (2.1 percent of a total of 11, 428) . The final unweighted analysis sample sizes were 1,874 and 2,128 for males and females, respectively, in NHES I; 3,612 and 4,886 for males and females in NHANES I; and 3,769 and 4,172 for males and females in NHANES II. Across the three surveys, the sample included 8,053 white males, 9,565 white females, 1,202 black males, and 1,619 black females.
Measurements
Blood pressure was measured with mercury sphygmomanometers by trained observers using standardized protocols that were similar, although not identical, across surveys (7). More than one blood pressure measurement was taken for respondents in NHES I and NHANES n, but only data from the initial, seated blood pressure measurement were comparable across all three surveys. The initial measurement was thus selected for these analyses. Height and weight were measured in a consistent manner across surveys and were recorded automatically (8) (9) (10) . The weight of the standardized clothing worn in NHES I (2.0 pounds (0.91 kg) (8)) differed from that of the other two surveys (0.5 pounds (0.23 kg) (9, 10)). The difference (1.5 pounds (0.68 kg)) was subtracted from each NHES I respondent's weight. A cutpoint of BMI <25, the upper limit of recommended weight in several published weight classifications (11) , was used to differentiate overweight and non-overweight strata.
Each survey included a question that could be used to classify persons according to antihypertensive medication use. NHES I respondents were considered to be taking anithypertensive medication if they reported having been told that they had high blood pressure and answered "yes" to a question on whether they were taking high blood pressure medication (4) . NHANES I respondents were asked whether they had used "any medicine, drugs, or pills for high blood pressure" during the past 6 months (5). Persons who responded that they used such substances "regularly" or "occasionally" were classified as taking medication. NHANES II respondents were considered to be taking antihypertensive medication if they indicated that they had ever been told they had high blood pressure or hypertension, a doctor had ever prescribed medicine for their high blood pressure or hypertension, and they were currently taking such medication (6) .
Statistical analyses
Both systolic and diastolic blood pressures were analyzed. However, because of measurement protocol differences across surveys that complicate the interpretation of diastolic blood pressure trends (12) , only the systolic blood pressure results are presented in detail. Analyses incorporated adjustments for sample weights and for the complex sample design, unless otherwise stated.
Blood pressure values were partitioned into four categories based on thresholds derived from the NHES I data for 35-to 44-year-old adults who were not taking antihypertensive medication. The systolic blood pressure cutpoints, which corresponded to the 50th, 75th, and 90th percentiles of the weighted distributions within-sex, were 127.0, 139.9, and 154.7 mmHg for males and 120.6, 131.5, and 148.0 mmHg for females. These same cutpoints were applied to categorize the distributions for all age groups in each survey. We developed predictive models for the weighted proportions of persons in each of the four blood pressure categories defined by these three thresholds by fitting modified proportional odds models to the weighted cumulative logits associated with each of the three fixed thresholds.
Conceptually, proportional odds modeling is directly analogous to fitting three parallel logistic regression models with a common odds ratio for the race, BMI, and secular trend parameters at each blood pressure threshold while still incorporating the ordinal nature of the blood pressure thresholds. The cumulative logit is the logarithm of the ratio of the probability of being above a specified threshold to the corresponding probability of being below that threshold. Thus, the variation in the distribution of systolic blood pressure values over time was modeled in terms of the three cumulative logits corresponding to the three threshold cutpoints. The resulting data can be interpreted in terms of the odds of a randomly selected person's exceeding versus not exceeding a particular cutpoint in comparison with a randomly selected reference person. Within the model for each subgroup, the reference group was the group presumed to be at lowest risk: whites of a given sex and age with BMI less than 25 in NHES I. There is an inherent assumption that model effects are identical at each of the selected thresholds, so that the interpretation is the same for all cutpoints of the distribution in question.
The weighted proportions and complex samplebased covariance matrices were calculated within each age group using PC CARP (13) . Predictive models were fitted to the weighted cumulative logits, incorporating the complex sample-based covariance matrix, using SAS PROC CATMOD (14) . Fitted proportions, odds ratios, and 95 percent confidence intervals were subsequently estimated with SAS IML (15) .
Separate models were generated for each 10-year age group within the 35-to 74-year age range, withinsex. Within each age group, the data structure of the analysis was a 12 X 4 contingency table of observed frequencies and weighted proportions. The 12 rows corresponded to two levels of race (black or white) within two levels of BMI (<25 or >25) in each of the three surveys, and the four columns corresponded to the four ordinal blood pressure categories noted above.
Each model proceeded from the same baseline model containing one BMI effect, one race effect nested within each of the two BMI strata, separate linear secular trend effects across the three surveys for each of the four BMI X race subgroups, and separate nonlinear (quadratic) secular trend effects for each of the four BMI X race subgroups. Only significant trend parameters were retained in the model. A significant linear trend, for example, implied that the model-based odds ratio (on the logarithmic scale) of a randomly selected person's exceeding a particular cutpoint increased (decreased) over time at the estimated annual rate in comparison with a randomly selected reference person. Similarly, a significant quadratic effect (negative) implied that the slope of this trend in the odds (on a logarithmic scale) over time increased between 1960-1962 and 1971-1975 and then decreased between 1971-1975 and 1976-1980. This overall modeling approach, described elsewhere in detail (16, 17) , requires that all predictive factors be classified in a few discrete categories to avoid problems with small sample sizes. Instances of small sample sizes were handled with modified procedures to ensure stable results. However, in order to further investigate potential BMI effects within the two broad binary categories, especially above a BMI of 25, we refitted all final models within SAS PROC LOGISTIC (18) , incorporating an effect for BMI as a continuous variable. This methodology permitted the inclusion of sampling weights but could not accommodate adjustments for the complex sample design effects across the three surveys.
To investigate the effects of antihypertensive drug therapy, in the final models we first estimated the odds ratios ignoring blood pressure treatment (observed data) and then recomputed them after executing a procedure in which all respondents who reported drug therapy and whose observed blood pressure was below the 90th percentile reference cutpoint (154.7 mmHg for males and 148.0 mmHg for females) were reassigned to the highest category of the distribution. This imputation approach not only adjusted for the use of antihypertensive medication but also reflected the extent of blood pressure lowering among those taking medication. That is, only those taking medication whose blood pressure was below the reference 90th percentile cutpoint were affected by the imputation procedure. To ensure comparability when investigating the effects of drug therapy, we included the same set of independent variables in the predictive models for the observed data and the imputed data, provided that a given term was statistically significant in either of the two models.
Goodness-of-fit statistics indicated that the final cumulative logit models accounted for at least 80 percent of the total variation in seven of 16 analysis groups (i.e., observed and imputed models for four age groups within each sex) and at least 69 percent of the total variation in all but one age-sex stratum. The models for males aged 65-74 years had an unacceptably poor fit (less than 40 percent of the total variation was explained), and those data are therefore not presented.
RESULTS

Secular trends in systolic blood pressure distributions and antihypertensive medication use
Mean systolic blood pressures and selected percentiles for systolic blood pressure across the three surveys are shown in table 1 for each of the four age groups, within-sex. A downward trend in systolic blood pressure between 1960-1962 (NHES I) and 1976-1980 (NHANES H) is evident, particularly at older ages. Trends in antihypertensive medication use are shown for males and females in figures 1 and 2, respectively. The percentage of persons taking antihypertensive medication generally increased across age groups and surveys, was higher in blacks than in whites within each BMI category, and was higher among persons with BMI ^ 25 within each race and age group.
Blood pressure category by medication status and BMI status
As was noted above, persons who reported taking antihypertensive medication were first classified as having a systolic blood pressure above or below the sex-specific 90th percentile reference threshold. The results of this classification procedure are shown in table 2, expressed as the proportion below the cutpoint. If all persons taking antihypertensive medication had well-controlled systolic blood pressures, then few or none of the observations would have been in the top category, and all percentages in table 2 would be near 100 percent. However, as is shown, the extent of blood pressure lowering in persons reporting drug therapy was variable. In a few subgroups of black respondents in NHES I, the percentage below the cutpoint was zero; i.e., everyone in that subgroup who reported using antihypertensive medication nevertheless had a relatively high blood pressure reading. There was no consistent pattern by age, race, or sex; this may have been influenced by the small numbers of persons reporting antihypertensive drug therapy in some subgroups.
The blood pressure category (i.e., above or below the reference 90th percentile) of persons taking antihypertensive medication was also examined according to various BMI parameters (e.g., proportion with BMI ^ 25, mean BMI, and median BMI). Persons on drug therapy whose blood pressures were above the reference 90th percentile threshold generally had higher BMI levels than those on drug therapy who had lower blood pressures. BMI differences between persons whose hypertension was better controlled versus (1976) (1977) (1978) (1979) (1980) . t Analyses were restricted to respondents with nonmissing information on systolic blood pressure, diastolic blood pressure, and high blood pressure treatment status.
Race-BMI category and survey Race-BMI category and survey Model-based estimates of secular trends, race, and BMI effects on systolic blood pressure assuming drug therapy versus no drug therapy
The cumulative logit models generated to evaluate the effects of time, race, and BMI on systolic blood pressure are shown in table 3 for males and in table 4 for females. Within each race, sex, and age group, these odds ratios compared persons in each survey with whites in the lower of the two BMI strata (BMI < 25) in the earliest survey (NHES I). Decreasing odds ratios across rows reflect a downward secular trend, and the linear trend in the odds was statistically significant (a = 0.01) for the rows highlighted in bold type. Few significant quadratic terms were noted, but where present they are mentioned below.
Males. In the models with no adjustment for effects of drug therapy, significant decreases in systolic blood pressure were observed across surveys in seven of the 12 strata presented for males (table 3) . For example, among 35-to 44-year-old white males with BMI < 25, a randomly selected NHANES I and NHANES II respondent was, respectively, 60 percent and 50 percent less likely than a randomly selected white male in the same BMI stratum in NHES I to have a blood pressure exceeding a given threshold. Decreasing systolic blood pressure over time was also observed in 35-to 44-year-old white and black males with BMI 2: 25, in 45-to 54-year-old white males with BMI < 25, in 45-to 54-year-old black males regardless of BMI category, and in 55-to 64-year-old black males with BMI £: 25. The quadratic term was significant for the trend in odds ratios among 45-to 54-year-old black males with BMI > 25. For the latter group, there was a significant decrease in systolic blood pressure between 1971-1975 and 1976-1980 but an increase between 1960-1962 and 1971-1975 .
The imputed models assuming that no drug therapy was in effect can be interpreted in the same manner as above for the data with no imputations, except that all blood pressure distributions, including those for the reference group (NHES I white males with BMI < 25), have been altered so that all persons reporting use of antihypertensive medication are in the uppermost category of the distribution. As noted previously, the extent to which the distributions in a given subgroup change is a function of the proportion taking medication and of whether their blood pressures were below the 90th percentile reference threshold before the imputation. The finding of a decrease in systolic blood pressure over time in three strata of 35-to 44-year-old males was unchanged under the assumption that no drug therapy was in effect. However, among 45-to 54-year-old males, the pattern in the imputed data was less favorable than the pattern seen prior to imputation: 1) a significant linear decrease in systolic blood pressure was no longer observed in low-BMI white males or in black males in this age group (although the significant quadratic term in the 45-to 54-year-old black males with BMI ^ 25 remained); and 2) in white males with BMI ^ 25, an increase in systolic blood pressure over time, suggested in the observed data, became statistically significant in the model assuming no drug therapy. The significant decrease in systolic blood pressure in 55-to 64-year-old black males with BMI 5: 25 also became nonsignificant under the assumption that no drug therapy was in effect Differences in odds ratios by race and BMI were evident in both the observed and the imputed models in table 3; these differences were statistically significant in both the observed and the imputed models, except for one case (there was no race effect in males aged 55-64 years under the assumption of no drug therapy (p = 0.43)). That is, within-race, odds ratios for males with BMI ^ 25 were greater than those for males with BMI < 25, reflecting a consistent association of higher BMI with an overall higher level of blood pressure. Within BMI strata, odds ratios for black males were higher than those for white males, reflecting a consistent association of black race with higher systolic blood pressure. The odds ratios for black males with BMI ^ 25 then reflected the combined effects of race and BMI on systolic blood pressure in each time period. In spite of the decline in blood pressure across surveys, an NHANES II black male with BMI ^ 25 was still 2-3 times as likely as an NHES I white male with BMI < 25 to have a systolic blood pressure exceeding a given threshold (i.e., odds ratios were 3.1, 1.8, and 3.2, respectively, for NHANES n black males aged 35-44, 45-54, and 55-64 years who had BMI levels > 25).
Females. Model results for females are presented in table 4. Before imputation, significant decreases in systolic blood pressure over time were observed in 10 of the 16 strata: in 35-to 44-year-olds, except white females with BMI ^ 25; in 45-to 54-year-old white females; in 55-to 64-year-old white females with BMI > 25; and in all 65-to 74-year-old females. A significant quadratic term in the model for 35-to 44-year-old females with BMI < 25 suggested a steeper decline between 1971-1975 and 1976-1980 than between 1960-1962 and 1971-1975 . In the im-Drug Therapy and Systolic Blood Pressure Trends puted models, findings of significant declines in systolic blood pressure were unchanged for females below the age of 65, except for attenuation to nonsignificance of the decline for 45-to 54-year-old females with BMI a 25. Declines in systolic blood pressure across surveys among females aged 65-74 years, observed consistently before the imputation, were no longer present under the assumption of no drug therapy. Black females and females with BMI a 25 had significantly higher systolic blood pressures than white females and females with BMI < 25, respectively, with some exceptions for the race effect. Before the imputation, race effects were suggested but were not statistically significant at a = 0.01 in 35-to 44-year-old females with BMI > 25 (p = 0.014) and 65-to 74-year-old females with BMI < 25 (p = 0.04); in both cases, these effects met the criterion of significance under the assumption of no drug therapy. No significant race effect was evident among 55-to 64-year-old females either before (p = 0.79) or after \p = 0.14) the imputation. BMI effects were highly significant throughout.
Additional analyses of BMI effects.
A more refined examination of the effects of BMI on systolic blood pressure was carried out using logistic regression models in which BMI could be included as a continuous variable. This was of particular interest with respect to clarification of racial differences that were independent of BMI, since the overall distribution of BMI values in black females was substantially higher than that for white females. For example, in 1976-1980 (NHANES II), the 85th percentiles of BMI for black females in the 10-year age groups included here ranged from 33.6 to 35.2, as compared with a range of 30.4-31.9 for white females (10) . In addition to controlling for residual confounding due to BMI as such, this analysis also reduced the potential impact of measurement artifacts associated with differences in the sphygmomanometer cuff sizes available across the three surveys (12) , because BMI and arm circumference are highly correlated (19) . Most of the race effects observed in the cumulative logit models were also significant in the logistic regression models, although in some strata (45-to 54-year-old males with BMI < 25, 55-to 64-year-old males with BMI > 25, and 35-to 44-year-old females with BMI S: 25) there was no longer an impression of a significant race effect in either the observed data or the imputed data, or both, with this better adjustment for BMI. In one case-the model for 55-to 64-year-old males with BMI < 25 assuming no drug therapy-a highly significant race effect emerged where none had been seen in the cumulative logits.
Diastolic blood pressure
Examination of means and percentiles for the diastolic blood pressure distributions suggested marked increases (about 4 mmHg) between the 1960-1962 and 1971-1975 surveys, followed by a modest decrease (about 1 mmHg) between 1971-1975 and 1976-1980 . In the cumulative logit models for males, there were some significant quadratic terms, but there appeared to be a significant increase in diastolic blood pressure over time in about half of the age-race-BMI subgroups, with little change under the assumption that no drug therapy was in effect. Means and percentiles of diastolic blood pressure for females gave a mixed picture of the changes across surveys. No clear pattern of change was evident in the cumulative logit models for diastolic blood pressure models in females, before or after the imputation, despite the appearance in several subgroups of significant quadratic terms suggestive of a substantial rise in diastolic blood pressure between 1960-1962 and 1971-1975 that was subsequently reversed between 1971-1975 and 1976-1980 . Effects of race and BMI on diastolic blood pressure were similar to those noted for systolic blood pressure; that is, being black and having a BMI ^ 25 were consistently associated with higher diastolic blood pressures in both males and females. These within-survey effects would presumably be less influenced by the potential lack of comparability in diastolic blood pressure measurements across surveys.
DISCUSSION
This analysis was motivated by an interest in identifying blood pressure trends relevant to primary prevention of hypertension. We attempted to estimate blood pressure trends that would have occurred in the absence of antihypertensive drug therapy, which increased in prevalence during this period. The categorical (i.e., cumulative logit) approach to modeling of blood pressure distributions is informative if one is willing to assume that the blood pressures of persons treated with medication would have been in the upper part of the range if no treatment had occurred. This approach may be more appropriate than one in which blood pressure is handled as a continuous variable. Imputing a specific value for each individual who reported drug therapy would require several assumptions-e.g., about blood pressure levels at the time the medicine was prescribed, the efficacy of the medication^) prescribed, and adherence to the medication regimen (20) . No algorithm is available for calculating "correction factors" with which to derive, retrospectively, pretreatment blood pressures from measured blood pressures.
Our cutpoints (154.7 mmHg for males and 148.0 mmHg for females) for defining the upper category of the blood pressure distribution were derived statistically rather than based on presumed treatment thresholds. Since the definition of elevated systolic blood pressure that was relevant between 1960 and 1980 was >160 mmHg, it is highly likely that persons taking antihypertensive medication would have had blood pressures at least as high as our cutpoints. If anything, physicians who did not follow guidelines to the letter would have withheld treatment until a blood pressure level higher than the recommended treatment cutpoint had been observed (21) . To base the cutpoints on specific treatment thresholds would also have required knowledge or assumptions about the prescribing behavior of clinicians with respect to persons of a given race, sex, or age. Data on physician practices in prescribing antihypertensive medication do not provide a clear basis for making such assumptions (21) .
The observed decrease in mean systolic blood pressure and increase in the percentage of persons receiving antihypertensive drug therapy across time are consistent with prior reports from the National Center for Health Statistics (3, 7, 22) . The model-based estimates before imputation also supported the finding of an overall secular decline in systolic blood pressure, although not consistently in all age-race-BMI subgroups. The finding on the key question of interestthat is, how much of the decline was attributable to drug therapy-differed according to age. Above age 45, particularly for males aged 45-54 years and females aged 65-74 years, the declines in blood pressure appeared to be attributable to the increasing prevalence of antihypertensive therapy over time. This is a positive finding from the perspective of population blood pressure control, but not with respect to progress in primary prevention in these age groups during the time period studied. The apparent failure of drug therapy to impact substantially on the black-white disparity in blood pressure levels during this time period is also disappointing, given the special focus on blacks in screening programs. In addition, the data showing minimal or no differences in systolic blood pressure after imputation in several substrata in which antihypertensive therapy was prevalent underscore the fact that having a prescription for antihypertensive medication was not synonymous with adequate blood pressure control. A high proportion of persons who reported undergoing drug therapy had blood pressures that were already at the upper end of the distribution; this finding was more common among blacks and, particularly, among persons with BMI > 25. An association between being overweight and having poorer blood pressure control with antihypertensive medication was also reported by Schmieder et al. (23) based on screening of German civil servants. Unless this problem is addressed through improved pharmacologic or nonpharmacologic treatment, a lesser ability to control blood pressure with medication among overweight persons in the face of an increasing prevalence of obesity in the United States (24) may continue to limit gains in hypertension control.
The goal of antihypertensive drug therapy is to lower blood pressure sufficiently to limit damage to target organs and reduce morbidity and mortality (25, 26) . Although more numerous and better drugs for lowering blood pressure have become available since the 1970s, the ability to achieve this goal with medication alone can still be questioned. In the Third National Health and Nutrition Examination Survey (1988) (1989) (1990) (1991) , only 21 percent of persons being treated with antihypertensive medication had blood pressures that had been controlled to < 140/90 mmHg. While this is an improvement over the 11 percent of such persons whose blood pressure was controlled below this threshold in NHANES n, it indicates that most hypertensive persons being treated with medication may be bearing the financial costs and medical risks associated with chronic drug therapy without deriving the full benefit of treatment. The potential benefits of medication (as observed in efficacy trials, for example (25)) will only be observed in the general population if treatment is sufficient to lower blood pressure as effectively as in these trials, and this may be difficult to achieve (27) .
Considering this, our findings in the 35-to 44-yearolds are encouraging, since they suggest that factors favorable to primary prevention were reaching younger cohorts of US adults in the 1960s and 1970s. The observation of a significant secular decline in systolic blood pressure in this age group suggests a lower incidence of blood pressure elevation, possibly due to nonpharmacologic control of blood pressure. Our finding that the significance of the decline before imputation held up in the models assuming no drug therapy is consistent with the relatively low prevalence of antihypertensive drug therapy in this age group. This finding is also consistent with our prior observation of a decrease in systolic blood pressure among 18-to 34-year-olds (2), for whom drug treatment was not an issue.
Factors responsible for the decrease in systolic blood pressure cannot be directly identified with the data available. Candidates would include reductions in sodium intake, alcohol intake, or body weight or increases in physical activity among younger cohorts in the US population (28) . Of these factors, body weight is the only one for which national survey data can support sound inferences about time trends that might be parallel to the blood pressure trends. No declines in body weight were reported between 1960 and 1980 (24) , which indirectly suggests that changes in body weight were not responsible for the blood pressure trends. Since the 1970s, BMI levels have increased dramatically in the US population among children, adolescents, and adults (24, 29) . Thus, the strong association between higher BMI and higher blood pressure throughout these data and the finding that it was largely independent of drug therapy raises concern with respect to current and future blood pressure trends.
Our use of a single blood pressure reading leaves open the possibility of misclassification in the assignment of people to blood pressure categories, but such misclassification was probably similar across surveys, particularly for systolic blood pressure. However, as with any trend analysis, the possibility that increases or decreases over time may be due to artifacts introduced by protocol changes across surveys must be considered. Based on our own evaluation of the methods used in these national surveys and on a discussion of the relevant methodological issues by those directly involved in designing and conducting the surveys (12), we are confident that the systolic blood pressure trends found here reflect actual trends in the blood pressure distributions in the population. However, as we noted in "Materials and Methods," this is less certain for the observed trends in diastolic blood pressure, which are more subject to measurement bias (12) . Thus, the suggestion, in our model-based estimates for diastolic blood pressure, of increases over time does not necessarily contradict the more favorable findings for systolic blood pressure. Taken together, both sets of findings underscore the critical importance of tracking progress in primary prevention and providing for trend analyses in which underlying risk factor distributions can be evaluated. Observed trends that fail to exclude the effects of antihypertensive drug therapy may foster a false sense of security.
